Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared a post by
Multiple Myeloma Hub, on Twitter, adding the following:
“The majority of clinicians recommend against routine treatment of smoldering myeloma- instead preferring active surveillance.
Future/current trials must have observation/surveillance as control arm as that is the preferred/current standard of care.”
Quoting Multiple Myeloma Hub:
“Clinician preferences on the treatment of smoldering multiple myeloma, check out our key points below!
What treatment would you recommend for smoldering multiple myeloma? HCPs, share your thoughts below!”
Source: Manni Mohyuddin/Twitter and Multiple Myeloma Hub/Twitter